Swedish Orphan Biovitrum AB (Sobi) today announced that Lars Dreiøe has been appointed Senior Vice President Chief Quality & Compliance Officer (CQCO). Lars Dreiøe joins Sobi from global pharmaceutical company ALK in Denmark where he has been International Head of Quality.
Lars brings 20 years of experience in the Biotech and Pharmaceutical industry in the Quality, Manufacturing, Product Safety and Regulatory Affairs areas.
“We are delighted to welcome Lars to Sobi”, said Geoffrey McDonough, President and CEO at Sobi. “Sobi has been expanding the scope and geographic area of operations and the demands and complexity of external regulations governing our business has also increased. Lars will sustain and deepen our global commitment to quality in all aspects of our work, and will be a valuable addition to our senior leadership team.”
“I’m very much looking forward to joining the team at Sobi and to entering my new role – developing and delivering therapies at the highest level of quality to people living with a rare disease,” said Lars Dreiøe.
Lars will join Sobi on 18 January 2016.
Source: Swedish Orphan Biovitrum AB
The U.S. Patent and Trademark Office issued a patent to MedTrace for their method of diagnosing the human heart via 15O-water PET. The patented method is the foundation of the company’s software aQuant, currently under development. Hendrik “Hans” Harms, PhD and Senior Scientist at MedTrace, and Jens Soerensen, Professor and Clinical Advisor to MedTrace, are the originators of the method.
Teresa Graham, currently head of global product strategy for Roche pharma, will become the division’s new CEO next month, Roche said Thursday. Simultaneously, Roche is elevating Levi Garraway, chief medical officer, to the executive committee.
Fierce Pharma has obtained internal documents and video of a town hall meeting conducted this week describing what J&J called a “comprehensive review” of its portfolio. Moving forward, J&J plans to operate its vaccines and infectious diseases outfits as one group, the executives explained.
